Jesús F. San-Miguel, MD^1*, Vania T.M. Hungria, MD, PhD², Sung-Soo Yoon, MD PhD³, Meral Beksac, MD⁴, Meletios A. Dimopoulos⁵, Ashraf Elghandour, MD^6*, Wieslaw W. Jedrzejczak, MD^7*, Andreas Guenther, MD⁸, Thanyaphong Na Nakorn, MD^9*, Noppadol Siritanaratkul¹⁰, Robert L. Schlossman, MD¹¹, Jian Hou, MD, PhD^12*, Philippe Moreau^13*, Sagar Lonial, MD^14,15, Jae Hoon Lee, MD^16*, Hermann Einsele, MD¹⁷, Monika Sopala, PhD^18*, Bourras-Rezki Bengoudifa, MS^18*, Claudia Corrado, MD^18* and Paul G. Richardson¹¹

¹Clínica Universidad de Navarra-CIMA, Pamplona, Spain
²Hematology and Oncology, Santa Casa Medical School, Sao Paulo, Brazil
³Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
⁴Ankara University Faculty of Medicine Department of Hematology, Ankara, Turkey
⁵National and Kapodistrian University of Athens, Athens, Greece
⁶Alexandria University, Qesm Bab Sharqi, Egypt
⁷Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
⁸University of Kiel, Kiel, Germany
⁹Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
¹⁰Department of Pediatrics and Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
¹¹Dana-Farber Cancer Institute, Boston, MA
¹²Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China
¹³Department of Hematology, Nantes University Hospital, Nantes, France
¹⁴Winship Cancer Institute, Emory University, Atlanta, GA
¹⁵Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
¹⁶Gachon University Gil Medical Center, Incheon, South Korea
¹⁷Department of Medicine II, University Hospital Würzburg, Würzburg, Germany
¹⁸Novartis Pharma AG, Basel, Switzerland

Vincent L Hansen, MD¹, Morton Coleman, MD², Stephanie Elkins, MD³, Jeffrey P. Letzer^4*, Moshe Yair Levy, MD^5*, Lasika Seneviratne, MD^6*, Jessica Rine^7*, Marina White^7* and Emil T Kuriakose, MD⁷

¹Northern Utah Associates, Ogden, UT
²Center for Lymphoma and Myeloma, Weill Medical College of Cornell University, New York, NY
³University of Mississippi, Jackson, MS
⁴Bronson Battle Creek Cancer Center, Battle Creek, MI
⁵Charles A Sammons Cancer Center, Texas Oncology-Baylor, Dallas, TX
⁶SCORA Network, LLC, Torrance, CA
⁷Novartis Pharmaceuticals Corporation, East Hanover, NJ

Xavier Leleu, MD, PhD¹, Lionel Karlin^2*, Brigitte Kolb^3*, Mourad Tiab, MD^4*, Carla Araujo^5*, Nathalie Meuleman⁶, Thierry De Revel⁷, Pascal Bourquard^8*, Pascal Lenain, MD^9*, Murielle Roussel, MD^10*, Arnaud Jaccard, MD, PhD^11*, Marie-Odile Petillon^12*, Karim Belhadj-Merzoug^13*, Gerard Lepeu^14*, Marie-Lorraine Chretien^15*, Jean Fontan^16*, Philippe Rodon, MD¹⁷, Anna Schmitt^18*, Fritz Offner¹⁹, Laurent Voillat^20*, Sophie Cereja^21*, Frederique Kuhnowski^22*, Sophie Rigaudeau^23*, Olivier Decaux, MD, PhD^24*, Catherine Humbrecht-Kraut^25*, Jamile Frayfer^26*, Olivier Fitoussi^27*, Damien Roos Weil^28*, Jean Claude Eisenmann, MD^29*, Veronique Dorvaux^30*, Eric G. Voog, MD³¹, Cyrille Hulin^32*, Michel Attal³³, Philippe Moreau^34* and Thierry Facon, MD³⁵

¹Service d'hématologie et Thérapie cellulaire, Hopital La Mileterie, Poitiers, France
²Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
³Hopital Robert Debre, Reims Cedex, France
⁴Hopital la Roche Sur Yon, La Roche Sur Yon Cedex 9, France
⁵Centre Hospitalier de la côte basque, Bayonne, France
⁶Service des Maladies du Sang, Institut Bordet, Bruxelles, Belgium
⁷Dept. of Hematology, Hopital Percy, Clamart, France
⁸Hopital Caremeau, Nimes, France
⁹Hematology department, Centre Henri Becquerel, Rouen, France
¹⁰Cancer Research Center of Toulouse INSERM U1037, Team Pharmacogenomic of Multiple Myeloma, Toulouse, France
¹¹Department of Hematology, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts, CHU Limoges, Limoges, France
¹²Service des Maladies du Sang, CHU Lille, Lille, France
¹³Service Hematologie, CHU Henri Mondor, Creteil, France
¹⁴Service Hematologie, Centre Hospitalier H. Duffaut, Avignon, France
¹⁵Service Hematologie, CHU Dijon, Dijon, France
¹⁶Service Hematologie, CHU Besancon, Besancon, France
¹⁷Hematology, Centre Hospitalier, Perigueux, France
¹⁸Service Hematologie, Institut Bergonie, Bordeaux, France
¹⁹Hematology, Universitair Ziekenhuis Gent, Gent, Belgium
²⁰Service Hemato-Oncologie, Centre Hospitalier QWillian Morey, Chalon-sur-Saone, France
²¹Service Hematologie, CH Francilien, Corbeil-Essones, France
²²Service Hematologie, Institut Curie, Paris, France
²³Service Hematologie, CHU Andre Mignot, Versailles, France
²⁴Internal Medicine Department, CHU de Rennes, Rennes, France
²⁵Service Onco-Hematologie, CH Louis Pasteur, Colmar, France
²⁶Service Hematologie, CH Meaux, Meaux, France
²⁷Polyclinique Bordeaux Nord-Aquitaine, Bordeaux, France
²⁸Service Hematologie, AP-HP Groupe Hospitalier Pitie-Salpetriere, Paris, France
²⁹Hematology Department, CH Mulhouse, Mulhouse, France
³⁰Medecine Interne, Hopital Notre Dame de Bon Secours, Metz-Thionville, France
³¹Hematology Department, Le Mans, Centre Jean Bernard, Le Mans, France
³²Service Hematologie, CHRU Hopitaux de Brabois, NANCY CEDEX, France
³³CHU Toulouse Hopital Purpan, Toulouse, France
³⁴Department of Hematology, Nantes University Hospital, Nantes, France
³⁵Maladies du sang, CHU Lille Hôpital Claude-Huriez, Lille, France

Peter M. Voorhees, MD¹, Valeria Magarotto, MD^2*, Pieter Sonneveld, MD, PhD³, Torben Plesner, MD⁴, Ulf-Henrik Mellqvist, MD, PhD⁵, Claudia E. Paba-Prada, MD⁶, Catriona Byrne, RN⁷, Johan Harmenberg, MD, PhD^7*, Eva Nordstrom, MSc, MBA^7*, Antonio Palumbo, MD² and Paul Richardson, MD⁶

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
³Hematology, Erasmus Medical Center, Rotterdam, Netherlands
⁴Dept. of Hematology, Vejle Hospital, Vejle, Denmark
⁵Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
⁶Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Oncopeptides AB, Stockholm, Sweden

Toshihisa Satta^1*, Norihiro Yamaguchi^1*, Adriana Malone, MD², James Talcott^3* and Ajai Chari, MD²

¹Department of Internal Medicine, Mount Sinai Beth Israel, New York, NY
²Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³Hematology and Medical Oncology, Mount Sinai Beth Israel, New York, NY

David S Siegel, MD, PhD¹, Katja C. Weisel^2*, Meletios A. Dimopoulos³, Rachid Baz⁴, Paul G. Richardson⁵, Michel Delforge⁶, Kevin Song⁷, Jesus San Miguel, MD, PhD⁸, Philippe Moreau^9*, Xin Yu^10*, Kevin Hong^10*, Lars Sternas^10*, Mohamed H Zaki¹⁰ and Antonio Palumbo¹¹

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Hematology & Oncology, Department of Medicine, University Hospital Tuebingen, Tuebingen, Germany
³National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶University Hospital Leuven, Leuven, Belgium
⁷Hematology, Vancouver General Hospital, Vancouver, BC, Canada
⁸Universidad de Navarra, Navarra, Spain
⁹University of Nantes, Nantes, France
¹⁰Celgene Corporation, Summit, NJ
¹¹University of Torino, Torino, Italy

Neeraj Gupta, PhD^1*, Michael J Hanley, PhD^1*, Karthik Venkatakrishnan, PhD^1*, Raymond Perez, MD^2*, Robin E Norris, MD^3*, John Nemunaitis, MD^4*, Huyuan Yang, PhD^1*, Gerald Falchook, MD^5*, Richard Labotka, MD, MS¹ and Siqing Fu, MD, PhD^6*

¹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²University of Kansas Clinical Research Center, Fairway, KS
³University Hospitals of Cleveland, Cleveland, OH
⁴Mary Crowley Cancer Research Centers, Dallas, TX
⁵Sarah Cannon Research Institute at HealthONE, Denver, CO
⁶The University of Texas MD Anderson Cancer Center, Houston, TX

Anna Kalff, MD¹, Kate Reed^2*, Tiffany T. Khong, PhD³, Sridurga Mithraprabhu, Post doc^1*, Malarmathy Ramachandran^1*, Richard Hall^4*, Krystal Bergin, MBBS^5* and Andrew Spencer³

¹Myeloma Research Group, ACBD, Alfred Health-Monash University, Melbourne, Australia
²Haematology Department, Alfred Health, Melbourne, Australia
³Myeloma Research Group, Alfred Hospital-Monash University, Melbourne, Australia
⁴Haematology department, Alfred Health, Melbourne, Australia
⁵Myeloma Research Group, Alfred Health-Monash University, Melbourne, Australia

Mohamad Mohty, MD, PhD¹, Evangelos Terpos², Maria-Victoria Mateos^3*, Antonio Palumbo, MD⁴, Sandra Lejniece^5*, Meral Beksac, MD⁶, Mohamed Amine Bekadja^7*, Wojciech Legiec^8*, Meletios Dimopoulos⁹, Svetlana Stankovic, PhD^10*, Maria Soledad Durán^11*, Valerio De Stefano, MD^12*, Alessandro Corso, MD^13*, Yulia Kochkareva^14*, Edward Laane, MD, PhD^15*, Christian Berthou, MD, PhD^16*, Hans-Juergen Salwender, MD^17*, Zvenyslava Masliak^18*, Valdas Pečeliūnas^19*, Wolfgang Willenbacher, MD^20*, João Da Silva^21*, Vernon Louw²², Damir Nemet, MD, PhD²³, Zita Borbényi, MD, PhD^24*, Uri Abadi, MD^25*, Robert Schou Pedersen^26*, Peter Cernelc^27*, Anna Potamianou, MD, PhD^28*, Catherine Couturier^29*, Robert Olie, PhD^30*, Caroline Feys, MSc, MBA^31*, Florence Thoret-Bauchet^32* and Mario Boccadoro, MD^33*

¹Hematology Department, Saint-Antoine Hospital, AP-HP, Universite Pierre et Marie Curie, Paris, France
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
³Hematology, University Hospital of Salamanca, Salamanca, Spain
⁴Department of Hematology, University of Torino, Torino, Italy
⁵Chemotherapy and Hematology Clinic, Riga East Clinical University Hospital, Riga, Latvia
⁶Department of Hematology, Ankara University, Ankara, Turkey
⁷Hematology and Cell Therapy, ETABLISSEMENT HOSPITALIER UNIVERSITAIRE (EHU) 1st NOVEMBER, Oran, Algeria
⁸Medical University of Lublin, Lublin, Poland
⁹Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁰University Clinic of Hematology, Skopje, Macedonia
¹¹HEMATOLOGIA, COMPLEJO HOSPITALARIO DE JAEN, Jaén, Spain
¹²Hematology, Catholic University, Rome, Italy
¹³Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
¹⁴City Outpatient Clinic 68 of Healthcare Department of Moscow, Branch 3, State Budget Healthcare Institution of Moscow, Moscow, Russia
¹⁵North Estonia Medical Centre Foundation, Tallinn, Estonia
¹⁶Hematology, Université de Bretagne Occidentale (UBO), Brest, France
¹⁷Asklepios Klinik Altona, Hamburg, Germany
¹⁸Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine, Lviv, Ukraine
¹⁹Vilnius University Hospital Santariskiu Klinikos Hematology, Oncology and Transfusion Medicine Center, Vilnius, Lithuania
²⁰Haematologie & Onkologie, Universitätsklinik Innsbruck Innere Medizin V, Innsbruck, Austria
²¹Department of Medical Oncology and Hematology, University Health Network (UHN), Toronto, Canada
²²University of the Free State, Bloemfontein, South Africa
²³Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia
²⁴Haematology, University of Szeged, Szeged, Hungary
²⁵Hematology, Meir Medical Center, Kfar Saba, Israel
²⁶Regionshospitalet i Holstebro, Medicinsk Afdeling, Holstebro, Denmark
²⁷University Medical Centre Ljubljana, Ljubljana, Slovenia
²⁸EMEA Medical, Janssen, Athens, Greece
²⁹Janssen-Cilag, Issy-les-Moulineaux, France
³⁰Medical Affairs EMEA, Janssen-Cilag AG, Zug, Switzerland
³¹Medical Affairs, Janssen Pharmaceutica NV, Beerse, Belgium
³²Janssen, Issy-les-Moulineaux, France
³³Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria (AOU) S. Giovanni Battista, Torino, Italy

Marc S Raab, MD, PhD¹, Manik Chatterjee, MD^2*, Hartmut Goldschmidt, MD³, Hermine Agis, MD^4*, Igor W Blau, MD, PhD^5*, Hermann Einsele, MD², Monika Engelhardt, MD⁶, Barbara Ferstl, MD^7*, Martin Gramatzki, MD⁸, Christoph Röllig, MD^9*, Katja C. Weisel^10*, Pia Klöpfer, MD^11*, Dominika Weinelt, MD^11*, Stefan Härtle, PhD^11* and Christian Peschel, MD¹²

¹Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
²Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany
³Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany
⁴Department of Medicine I, University Hospital of Internal Medicine – AKH Wien, Vienna, Austria
⁵Department of Internal Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany
⁶Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
⁷Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nuernberg, Erlangen, Germany
⁸Department of Medicine, University Hospital Schleswig-Holstein Division of Stem Cell Transplantation and Immunotherapy, Kiel, Germany
⁹Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
¹⁰Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany
¹¹MorphoSys AG, Martinsried, Germany
¹²Department of Internal Medicine III, Technical University of Munich, Munich, Germany

Paul G. Richardson, MD¹, Craig Hofmeister², Noopur S. Raje, MD³, David S Siegel, MD, PhD⁴, Sagar Lonial, MD⁵, Jacob P. Laubach⁶, Yvonne A Efebera, MD⁷, David H. Vesole, MD⁸, Ajay K Nooka^9*, Jacalyn Rosenblatt¹⁰, Mohamed H Zaki¹¹, Jennifer Herring^11*, Yan Li, PhD^11*, Sheetal Shah^11*, Min S Chen^11* and Kenneth C Anderson¹²

¹Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Division of Hematology, Ohio State University Medical Center, Columbus, OH
³Massachusetts General Hospital Cancer Center, Boston, MA
⁴Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
⁵Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁶Dana-Farber Cancer Institute, Harvard Medical School, Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Boston, MA
⁷The Ohio State University, Columbus, OH
⁸John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁹Division of BMT, Winship Cancer Institute - Hematology and Medical Oncology, Emory University, Atlanta, GA
¹⁰Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
¹¹Celgene Corporation, Summit, NJ
¹²The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Jakub Krejcik^1*, Tineke Casneuf^2*, Inger Nijhof^3*, Bie Verbist^2*, Jaime Bald^4*, Torben Plesner, MD¹, Kevin Liu^5*, Niels W.C.J. van de Donk³, Brendan Weiss^6*, Tahamtan Ahmadi^4*, Henk M. Lokhorst³, Tuna Mutis^3* and A. Kate Sasser^4*

¹Vejle Hospital and University of Southern Denmark, Vejle, Denmark
²Janssen Research & Development, Beerse, Belgium
³Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
⁴Janssen Research & Development, LLC, Spring House, PA
⁵Janssen Research & Development, LLC, Raritan, NJ
⁶Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Philippe Moreau, MD, PhD^1*, Asher Chanan-Khan, MD^2*, Andrew W. Roberts, MBBS, PhD³, Amit B. Agarwal, MD, PhD⁴, Thierry Facon⁵, Shaji Kumar, MD⁶, Cyrille Touzeau, MD^1*, David Darden, MS^7*, Lura Morris, BA^7*, Jeremy Ross, PhD^7*, Ahmed H Salem, PhD^7*, Wijith Munasinghe, PhD^7*, Ming Zhu, PhD^7*, Joel Leverson, PhD^7*, Paulo Maciag, MD^7*, Sari Heitner Enschede, MD^7*, Maria Verdugo, MD^7*, Rod A. Humerickhouse, MD, PhD⁷ and Simon Harrison, MD^8*

¹Nantes University Hospital, Hôtel Dieu, Nantes, France
²Mayo Clinic, Jacksonville, FL
³Royal Melbourne Hospital, Melbourne, Australia
⁴Department of Hematology and Oncology, University of Arizona, Tucson, AZ
⁵Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷AbbVie Inc., North Chicago, IL
⁸Dept. of Hematology, Peter MacCallum Cancer Center, Melbourne, Australia

P. Leif Bergsagel, MD¹, Martha Q. Lacy, MD², David Dingli, MD, PhD², Shaji K. Kumar, MD², Sikander Ailawadhi, MD³, Angela Dispenzieri, MD², Francis Buadi, MD², Morie A. Gertz, MD², A. Keith Stewart, MD¹, Craig B. Reeder, MD¹, Heidi E. Kosiorek, MS^1*, Amylou C. Dueck, PhD¹, Yi Lin, MD, PhD², Asher Alban Chanan-Khan, MD³ and Marta Chesi, PhD¹

¹Mayo Clinic, Scottsdale, AZ
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL

Ruben Niesvizky, MD¹, Paul G. Richardson, MD², Nashat Y. Gabrail, MD^3*, Sumit Madan, MD^4*, Andrew J. Yee, MD⁵, Steven N Quayle, PhD^6*, Ingrid Almeciga-Pinto, PhD^6*, Simon S Jones, PhD^6*, Lee Houston^6*, Denise Hayes^6*, John Van Duzer, PhD^6*, Catherine Wheeler, MD^6*, Nikolaus S. Trede, MD, PhD⁶ and Noopur S. Raje, MD⁵

¹Center of Excellence for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY
²Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Gabrail Cancer Center, Canton, OH
⁴Hematology-Oncology, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶Acetylon Pharmaceuticals, Inc., Boston

Suzanne Lentzsch, MD, PhD¹, Raymond L. Comenzo, MD², Jeffrey A Zonder, MD³, Keren Osman, MD^4*, Miao Susanna^5*, Daniel Backenroth^5*, Daniel Otap^5*, Wei-Yann Tsai^6*, Siva Pregja^7*, Shahzad Raza, MD^8*, Vaishali Sanchorawala, MD⁹ and Heather J Landau, MD¹⁰

¹Division of Hematology/Oncology, Columbia University, New York, NY
²Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
³Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁴Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
⁵Columbia University Medical Center, New York, NY
⁶Columbia University Medical Center, New York
⁷The Barbara Ann Karmanos Cancer Institute, Detroit, MI
⁸Division of Hematology/Oncology, Columbia University Medical Center, New York, NY
⁹Boston Univ. Med. Ctr., Boston, MA
¹⁰Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Eileen Boyle^1*, Guillemette Fouquet^1*, Julie Lejeune^2*, Salomon Manier, MD³, Lucile Musset^4*, Claire Bories^1*, Remy Dulery, MD^5*, Stéphanie Guidez^1*, Sarah Bonnet^6*, Brigitte Onraed^7*, Jean-Luc Faucompre^8*, Sabine Tricot^9*, Stephanie Poulain^10*, Veronique Leblond, MD¹¹, Kym Snell^12* and Xavier Leleu, MD¹³

¹Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
²Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France
³Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Deapartment of immunology, Hospital Pitie-Salpetriere, Paris, France
⁵Service des Maladies du Sang, Hopital Claude Huriez, CHRU Lille, Lille, France
⁶Hospital Claude Huriez, CHRU Lille, Lille, France
⁷Service de biochimie proteine, Hospital Huriez, CHRU Lille, Lille, France
⁸Hôpital Huriez, CHRU de Lille, Lille, France
⁹CHU, Valenciennes, France
¹⁰Hospital de Valenciennes, Valenciennes, France
¹¹Département d’ Hématologie, Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France
¹²University of Birmingham, Birmingham, United Kingdom
¹³CHRU-Hôpital Claude Huriez, Lille, France

Tadao Ishida, MD¹, Hideo Kimura, MD, PhD^2*, Koumei Kubo, MD^3*, Kazutaka Sunami, MD^4*, Shuji Ozaki, MD^5*, Naoki Takezako, MD^6*, Hiroshi Handa, MD, PhD^7*, Hiroshi Kosugi, MD^8*, Hirokazu Murakami, MD^9* and Kazuyuki Shimizu, MD^10*

¹Sapporo Medical University School of Medicine, Sapporo, Japan
²Department of Hematology, Kita-Fukushima Medical Center, Date, Japan
³Aomori Prefectural Central Hospital, Aomori, Japan
⁴Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan
⁵Department of Hematology Tokushima Prefectural Central Hospital, Tokushima, Japan
⁶Department of Hematology Disaster Medical Center of Japan, Tachikawa, Japan
⁷Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
⁸Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japan
⁹Department of Laboratory Science, Gunma University Graduate School of Health Science, Maebashi, Japan
¹⁰Hematology 1, Tokai Central Hospital, Kakamigahara, Japan

Rajshekhar Chakraborty, MBBS^1,2*, Shaji Kumar, MD¹, Francis Buadi, MD¹, David Dingli, MD, PhD, FRCP¹, Angela Dispenzieri, MD¹, Suzanne R. Hayman, MD¹, William J Hogan, MD¹, Prashant Kapoor, MD¹, Martha Q. Lacy, MD¹, Nelson Leung, MD³ and Morie A. Gertz, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Hospitalist services, Essentia Health St. Joseph's Hospital, Brainerd, MN
³Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Efstathios Kastritis, MD^1*, Evangelos Terpos¹, Maria Gavriatopoulou^1*, Magdalini Migkou^1*, Evangelos Eleutherakis-Papaiakovou^1*, Dimitrios Ziogas^1*, Ioannis Panagiotidis^1*, Despoina Fotiou^1*, Dimitra Gika^1*, Despoina Kalapanida^1*, Eftychia Kafantari^1*, Maria Roussou^1*, Flora Zagouri^1*, Stavroula Giannouli^2*, Athanasios Zomas^3*, Kostas Konstantopoulos^4* and Meletios A. Dimopoulos⁵

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Second Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department of Hematology, "St Anargiri" Cancer Hospital, Athens, Greece
⁴Department of Hematology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

John Reneau, MD, PhD¹, Dennis Asante, MS^2*, Holly Van Houten, BA^3,4*, Francis Buadi, MD⁵, Amir Lerman, MD^6* and Joerg Herrmann, MD^6*

¹Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Department of Health Sciences Research, Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
³Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN
⁴Optum Labs, Cambridge, MA
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN

Johan Lund, MD^1*, Sigrid Karstorp, MD^1*, Evren Alici, MD, PhD^2,3*, Astrid Gruber, MD, PhD⁴, Birgitta Lauri, MD^5*, Cecilie Blimark, MD, PhD^6*, Agneta Swedin, MD, PhD^7*, Markus Hansson, MD, PhD^8*, Karin Forsberg, MD^9*, Lucia Ahlberg, MD^10*, Carlsson Conny, MD^11*, Anders Waage, MD, PhD¹², Peter Gimsing^13*, Annette Juul Vangsted, MD, PhD^14*, Ulf Christian Frølund, MD^15*, Mats Hardling^16*, Ulf-Henrik Mellqvist, MD, PhD¹⁷ and Hareth Nahi^18*

¹Hematology Department, Karolinska University Hospital, Stockholm, Sweden
²Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden
³Vaccine & Gene Therapy Institute of Florida, Port Saint Lucie, FL
⁴Hematology Department, Karolinska Institute, Stockholm, Sweden
⁵Department of Hematology, Sunderbyn Hospital, Sunderbyn-Luleå, Sweden
⁶Hematology Department, Sahlgrenska University Hospital, Gothenburg, Sweden
⁷VO Hematologi, Lund University Hospital, Lund, Sweden
⁸Hematology Department, Skåne University Hospital, Lund, Sweden
⁹Hematology Department, Norrlands University Hospital, Umeå, Sweden
¹⁰Hematology Department, University Hospital, Linköping, Sweden
¹¹Department of Medicine, Hospital of Halland, Halmstad, Sweden
¹²Department of Hematology, St. Olavs University Hospital, Trondheim, Norway
¹³Department of Haematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
¹⁴Roskilde University Hospital, Roskilde, Denmark
¹⁵Hematology Department, Roskilde Hospital, Roskilde, Denmark
¹⁶Hematology Department, Uddevalla Hospital, Uddevalla, Sweden
¹⁷Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
¹⁸Haematology Centre, Karolinska University Hospital, Stockholm, Sweden

Daniel M Sullivan, MD¹, Trinayan Kashyap, MS^2*, Jana L Dawson, BS^3*, Yosef Landesman, PhD^2*, Steven Grant, MD⁴, Kenneth H. Shain, MD, PhD⁵, Yun Dai, PhD⁶, Michael Kauffman, MD, PhD⁷, Sharon Shacham^7* and Joel G Turner, PhD⁸

¹Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Karyopharm Therapeutics Inc., Newton, MA
³Bone Marrow Transplant Program, Moffitt Cancer Center, Tampa, FL
⁴Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
⁵Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶Virginia Commonwealth University, Richmond, VA
⁷Karyopharm Therapeutics, Inc, Newton, MA
⁸Bone Marrow Transplant Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Sandy W. Wong, MD^1*, Giovanni Palladini, MD, PhD², Ute Hegenbart, MD^3*, Heather Landau, MD⁴, Melissa Warner, BS^5*, Arnaud Jaccard, MD, PhD^6*, Herve Avet-Loiseau^7*, Timon Hansen, MD^8*, Joan Bladé, MD⁹, María Teresa Cibeira, MD^9*, Efstathios Kastritis, MD^10*, Stefan Schönland, MD^11* and Raymond L. Comenzo, MD⁵

¹Division of Hematology/Oncology, Tufts Medical Center, Boston, MA
²Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Department of Molecular Medicine, Pavia, Italy
³Amyloidosis Center, University Hospital Heidelberg, Heidelberg, Germany
⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁵Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
⁶Department of Hematology, Centre National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts, CHU Limoges, Limoges, France
⁷IUCT-Oncopole, Toulouse, France
⁸II. Department of Internal Medicine, Division of Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹Amyloidosis and Myeloma Unit, Department of Hematology, Servei d'Hematologia, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
¹⁰Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹¹Amyloidosis Center, Department of Internal Medicine V, Division of Hematology/Oncology/Rheumatology, University of Heidelberg, Heidelberg, Germany

Shaji K Kumar, MD¹, Betsy R. Laplant, MS^2*, Craig B. Reeder, MD³, Vivek Roy, MD, FACP⁴, Francis Buadi, MD¹, Morie A. Gertz, MD¹, Kristina Laumann^5*, Peter Leif Bergsagel, MD⁶, Angela Dispenzieri, MD¹, Prashant Kapoor, MD¹, Joseph Mikhael, MD⁷, Keith Stewart, MD⁸, Suzanne R. Hayman, MD¹, Yi L. Hwa, NP^1*, Thomas E. Witzig, MD¹, Sikander Ailawadhi, MD⁹, David Dingli, MD, PhD¹, Ronald S. Go, MD¹, Yi Lin, MD, PhD¹, Candido E. Rivera, MD¹⁰, S. Vincent Rajkumar¹ and Martha Q. Lacy, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Blood and Marrow Transplant Program, Mayo Clinic Arizona, Phoenix, AZ
⁴Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁵Mayo Clinic, Rochester, MN
⁶Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ
⁷Division of Hematology, Mayo Clinic, Scottsdale Campus, Scottsdale, AZ
⁸Mayo Clinic Arizona, Scottsdale, AZ
⁹Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL
¹⁰Hematology/Oncology, Mayo Clinic, Jacksonville, FL

Ajai Chari, MD¹, Hearn Jay Cho, MD, PhD¹, Samir Parekh, MD², Keren Osman, MD^3*, Talia Goldstein, BA^4*, Gillian Morgan^4*, Lisa La, MS/CCRP^5*, Crystle Carter, RN^6*, Donna Catamero^6*, Juliet Escalon^7*, Daniel Verina^7*, Erika Florendo^7*, Moon-hee Yum, RN^6*, Nadege Stevens, RN^6*, Jude Gullie, BA^4*, Elaine Chan, BS^4* and Sundar Jagannath, MD¹

¹Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York, NY
²Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY
³Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
⁴Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York
⁵Tisch Cancer Institute/ Multiple Myeloma Program, Mount Sinai School of Medicine, New York
⁶Mount Sinai Hospital, New York
⁷Ruttenberg Treatment Center, Mount Sinai Hospital, New York

Craig C Hofmeister, MD, MPH¹, Jesus G. Berdeja, MD², David H. Vesole, MD, PhD³, Attaya Suvannasankha, MD^4*, Tracy Parrott^5* and Rafat Abonour, MD⁶

¹Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
²Sarah Cannon Research Institute, Nashville, TN
³John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁴IU Simon Cancer Center, Indiana University, Indianapolis, IN
⁵Tragara Pharmaceuticals, Carlsbad, CA
⁶Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN

Amit Kumar Mitra, PhD^1*, Ujjal Mukherjee, PhD^2*, Taylor Harding^1*, Snigdhansu Chatterjee, PhD^2* and Brian G Van Ness, PhD¹

¹Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN
²School of Statistics, University of Minnesota, Minneapolis, MN

Efstathios Kastritis, MD^1*, Maria Roussou^1*, Despoina Fotiou^1*, Dimitrios Ziogas^1*, Maria Gavriatopoulou^1*, Kimon Stamatelopoulos^1*, Constantinos Pamboucas^1*, Elektra Papadopoulou^1*, Fotios Michas^1*, Aikaterini Lykka^1*, Evangelos Terpos¹, Meletios A. Dimopoulos² and Efstathios Manios^1*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Andrew J. Yee, MD¹, William Bensinger, MD^2*, Peter M. Voorhees, MD³, Jesus G. Berdeja, MD⁴, Paul G. Richardson, MD⁵, Jeffrey Supko, PhD^6*, David Tamang, PhD^7*, Simon S Jones, PhD^7*, Catherine Wheeler, MD^7*, Robert J Markelewicz Jr., MD^7* and Noopur S. Raje, MD¹

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Div. of Hematology/Oncology, University of North Carolina, Chapel Hill, NC
⁴Sarah Cannon Research Institute, Nashville, TN
⁵Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Massachusetts General Hospital, Boston
⁷Acetylon Pharmaceuticals, Inc., Boston

Kentaro Narita^*, Yoshiaki Usui, MD^*, Yasuhito Suehara, MD^*, Kota Fukumoto, MD^*, Manabu Fujisawa, MD^*, Masami Takeuchi, MD^* and Kosei Matsue, MD, PhD

Department of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan

Samuel A. Funt, MD^1,2*, David B. Page, MD^1,3*, Deepika Cattry, BSc, MSc^4*, Nikoletta Lendvai, MD, PhD^2,4, Hani Hassoun, MD^2,4, Ola Landgren, MD, PhD^4,5, Ivan M. Borrello, MD⁶ and Alexander M. Lesokhin, MD^2,4

¹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Weill Cornell Medical College, New York, NY
³Robert W. Franz Cancer Research Center, Providence Cancer Center, Portland, OR
⁴Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Weill Cornell Medical College, New York, NY
⁶Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD

Andrew R Branagan, MD^1,2, Eamon Duffy^2*, Chandra Sekhar Boddupall, PhD^1,2*, Randy A Albrecht, PhD^3*, Lin Zhang^1,2*, Rakesh Verma, PhD^1,2, Dennis L Cooper, MD^1,2, Stuart Seropian, MD^1,2, Terri L Parker, MD^1,4, Xiaopan Yao, PhD^1,4*, Thomas M Ferencz, RPh^1* and Madhav V Dhodapkar, MD^1,2

¹Yale Cancer Center, New Haven, CT
²Yale School of Medicine, New Haven, CT
³Icahn School of Medicine at Mt. Sinai, New York
⁴Hematology, Yale University School of Medicine, New Haven, CT

Dan T. Vogl, MD¹, Anas Younes, MD², Keith Stewart, MD³, Keith William Orford, MD, PhD^4*, Mark Bennett, PhD⁴, David S Siegel, MD, PhD⁵ and Jesus G. Berdeja, MD⁶

¹Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Mayo Clinic Arizona, Scottsdale, AZ
⁴Calithera Biosciences, South San Francisco, CA
⁵Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
⁶Sarah Cannon Research Institute, Nashville, TN